Modification with SUMO

Small ubiquitin‐related modifier (SUMO) is a protein moiety that is ligated to lysine residues in a variety of target proteins. The addition of SUMO can modulate the ability of proteins to interact with their partners, alter their patterns of subcellular localization and control their stability. It is clear that SUMO influences many different biological processes, but recent data suggest that it is particularly important in the regulation of transcription. Indeed, several transcription factors, such as Sp3, c‐Jun, c‐Myb and various nuclear receptors, have recently been shown to be subject to sumoylation and, although this modification can have a positive influence, a growing body of evidence highlights its role in the negative regulation of transcription. This review summarizes recent experiments focusing on sumoylation and transcriptional repression.

[1]  F. Nagy,et al.  Plant RanGAPs are localized at the nuclear envelope in interphase and associated with microtubules in mitotic cells. , 2002, The Plant journal : for cell and molecular biology.

[2]  J. Jiricny,et al.  Modification of the human thymine‐DNA glycosylase by ubiquitin‐like proteins facilitates enzymatic turnover , 2002, The EMBO journal.

[3]  E. Miska,et al.  The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase , 2002, The EMBO journal.

[4]  H. Yasuda,et al.  PIAS1 and PIASxα Function as SUMO-E3 Ligases toward Androgen Receptor and Repress Androgen Receptor-dependent Transcription* , 2002, The Journal of Biological Chemistry.

[5]  A. Dejean,et al.  c-Jun and p53 Activity Is Modulated by SUMO-1 Modification* , 2000, The Journal of Biological Chemistry.

[6]  Min Wang,et al.  The Small Ubiquitin-like Modifier-1 (SUMO-1) Consensus Sequence Mediates Ubc9 Binding and Is Essential for SUMO-1 Modification* , 2001, The Journal of Biological Chemistry.

[7]  S. Müller,et al.  Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Iñiguez-Lluhí,et al.  A Common Motif within the Negative Regulatory Regions of Multiple Factors Inhibits Their Transcriptional Synergy , 2000, Molecular and Cellular Biology.

[9]  Peter F. Johnson,et al.  Transcriptional Activity of CCAAT/Enhancer-binding Proteins Is Controlled by a Conserved Inhibitory Domain That Is a Target for Sumoylation* , 2002, The Journal of Biological Chemistry.

[10]  O. Jänne,et al.  Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor. , 2002, The Biochemical journal.

[11]  K. Horwitz,et al.  The Inhibitory Function in Human Progesterone Receptor N Termini Binds SUMO-1 Protein to Regulate Autoinhibition and Transrepression* , 2002, The Journal of Biological Chemistry.

[12]  Juliana Xu,et al.  Activation of p53 by Protein Inhibitor of Activated Stat1 (PIAS1)* , 2002, The Journal of Biological Chemistry.

[13]  H. Hofmann,et al.  Covalent Modification of the Transactivator Protein IE2-p86 of Human Cytomegalovirus by Conjugation to the Ubiquitin-Homologous Proteins SUMO-1 and hSMT3b , 2000, Journal of Virology.

[14]  F. Melchior,et al.  SUMO--nonclassical ubiquitin. , 2000, Annual review of cell and developmental biology.

[15]  M. Hochstrasser All in the Ubiquitin Family , 2000, Science.

[16]  F. Melchior,et al.  Ubiquitin‐Related Modifier SUMO1 and Nucleocytoplasmic Transport , 2002, Traffic.

[17]  O. Jänne,et al.  Ubc9 Interacts with the Androgen Receptor and Activates Receptor-dependent Transcription* , 1999, The Journal of Biological Chemistry.

[18]  O. Jänne,et al.  PIAS Proteins Modulate Transcription Factors by Functioning as SUMO-1 Ligases , 2002, Molecular and Cellular Biology.

[19]  H. Hurst,et al.  Transcription Factor AP-2 Interacts with the SUMO-conjugating Enzyme UBC9 and Is Sumolated in Vivo * , 2002, The Journal of Biological Chemistry.

[20]  H. Yasuda,et al.  Involvement of PIAS1 in the sumoylation of tumor suppressor p53. , 2001, Molecular cell.

[21]  A. Dejean,et al.  SUMO: of branched proteins and nuclear bodies , 2001, Oncogene.

[22]  J. Palvimo,et al.  Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  O. Jänne,et al.  The Nuclear Receptor Interaction Domain of GRIP1 Is Modulated by Covalent Attachment of SUMO-1* , 2002, The Journal of Biological Chemistry.

[24]  A. Dejean,et al.  The Nucleoporin RanBP2 Has SUMO1 E3 Ligase Activity , 2002, Cell.

[25]  N. Perkins,et al.  A Novel Transcriptional Repression Domain Mediates p21WAF1/CIP1 Induction of p300 Transactivation , 2000, Molecular and Cellular Biology.

[26]  L. Zon,et al.  SUMO-1 protease-1 regulates gene transcription through PML. , 2002, Molecular cell.

[27]  R. Sood,et al.  Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Erica S. Johnson,et al.  An E3-like Factor that Promotes SUMO Conjugation to the Yeast Septins , 2001, Cell.

[29]  L. Caskey,et al.  Preferential Interaction of Sentrin with a Ubiquitin-conjugating Enzyme, Ubc9* , 1997, The Journal of Biological Chemistry.

[30]  L. Zon,et al.  SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. , 2002, Molecular cell.

[31]  G. Suske,et al.  Transcription factor Sp3 is regulated by acetylation. , 2001, Nucleic acids research.

[32]  S. H. Baek,et al.  Versatile protein tag, SUMO: Its enzymology and biological function , 2002, Journal of cellular physiology.

[33]  L. Bruhn,et al.  PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. , 2001, Genes & development.

[34]  H. Saitoh,et al.  Functional Heterogeneity of Small Ubiquitin-related Protein Modifiers SUMO-1 versus SUMO-2/3* , 2000, The Journal of Biological Chemistry.

[35]  C. Mayhew,et al.  Regulation of Heat Shock Transcription Factor 1 by Stress-induced SUMO-1 Modification* , 2001, The Journal of Biological Chemistry.

[36]  G. Blobel,et al.  SUMO-1 Modification and Its Role in Targeting the Ran GTPase-activating Protein, RanGAP1, to the Nuclear Pore Complex , 1998, The Journal of cell biology.

[37]  A. Caudy,et al.  Regulation of Transcriptional Activation Domain Function by Ubiquitin , 2001, Science.

[38]  M. Matunis,et al.  SUMO-1 Modification Regulates the DNA Binding Activity of Heat Shock Transcription Factor 2, a Promyelocytic Leukemia Nuclear Body Associated Transcription Factor* , 2001, The Journal of Biological Chemistry.

[39]  A. Sharrocks,et al.  The ETS Domain Transcription Factor Elk-1 Contains a Novel Class of Repression Domain , 2002, Molecular and Cellular Biology.

[40]  R. DePinho,et al.  SUMO-1 Modification of Histone Deacetylase 1 (HDAC1) Modulates Its Biological Activities* , 2002, The Journal of Biological Chemistry.

[41]  Boris Pfander,et al.  RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO , 2002, Nature.

[42]  J. Markus,et al.  Covalent Attachment of the SUMO-1 Protein to the Negative Regulatory Domain of the c-Myb Transcription Factor Modifies Its Stability and Transactivation Capacity* , 2002, The Journal of Biological Chemistry.

[43]  F. Melchior,et al.  Transcription factor Sp3 is silenced through SUMO modification by PIAS1 , 2002, The EMBO journal.

[44]  M. Tatham,et al.  Polymeric Chains of SUMO-2 and SUMO-3 Are Conjugated to Protein Substrates by SAE1/SAE2 and Ubc9* , 2001, The Journal of Biological Chemistry.

[45]  M. Kaghad,et al.  Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. , 2000, The Journal of biological chemistry.